FSHR and obesity due to melanocortin 4 receptor deficiency: Understanding the interactions between obesity, biochemical pathways such as NO signaling, and genetic variants such as FSHR polymorphisms opens up new possibilities for improving reproductive health outcomes in affected individuals.